Healthcare Professional Survey to Assess the Effectiveness of Additional Risk Minimization Measures for Prescribing and Administration of Concentrated Insulin Human (Humulin R U-500 vial) Using the Dedicated U-500 Insulin Syringe (B5K-MC-B013)

09/04/2018
10/04/2018
EU PAS number:
EUPAS23516
Study
Planned
Documents
Study protocol
Initial protocol
English (579.65 KB - PDF) View document
Study results
Study report
Other information